{
  "docId": "019de513-5f4b-73dc-86be-8541064db857",
  "docSlug": "39fb009494023464f8efb2a436e710b2",
  "documentTitle": "Bausch+Lomb | Results Presentation Deck | 41 slides",
  "authorId": "bausch-lomb",
  "authorName": "Bausch + Lomb",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-06-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 7,
  "pageCount": 41,
  "prevPage": 6,
  "nextPage": 8,
  "slideType": "kpi_overview",
  "function": "summarize",
  "density": "overcrowded",
  "nDataPoints": 9,
  "notes": "The slide uses a four-column layout to present key performance indicators and strategic updates.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de513-5f4b-73dc-86be-8541064db857/7",
  "deckHref": "/decks/019de513-5f4b-73dc-86be-8541064db857",
  "deckJsonHref": "/decks/019de513-5f4b-73dc-86be-8541064db857.json",
  "deckAnchorHref": "/decks/019de513-5f4b-73dc-86be-8541064db857#slide-7",
  "components": [
    {
      "bbox": {
        "h": 0.3,
        "w": 0.2,
        "x": 0.06,
        "y": 0.5
      },
      "kind": "chart",
      "text": "Revenue breakdown by segment: Vision Care (63%), Surgical (20%), Ophthalmic Pharmaceuticals (17%)",
      "attrs": null,
      "subkind": "pie",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9e22b940-a97f-4bc5-9008-0aeb289efe19",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.2,
        "x": 0.06,
        "y": 0.35
      },
      "kind": "metric",
      "text": "+5% 1Q22 Organic Revenue",
      "attrs": null,
      "subkind": "big-number",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "15baa8cc-84fa-4b59-bb0e-7093ebab3c82",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.2,
        "x": 0.06,
        "y": 0.42
      },
      "kind": "metric",
      "text": "+4% 1Q22 Constant Currency",
      "attrs": null,
      "subkind": "big-number",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "49babd5e-d529-4533-85cd-6fa2cef586b7",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.2,
        "x": 0.06,
        "y": 0.28
      },
      "kind": "metric",
      "text": "+1% 1Q22 Reported Revenue",
      "attrs": null,
      "subkind": "big-number",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "deb3dac7-5135-4235-b7a4-d331d387dc35",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.6,
        "w": 0.2,
        "x": 0.55,
        "y": 0.2
      },
      "kind": "paragraph",
      "text": "Investing in Categories Growing Faster Than Market: ~2x increase in Daily SiHy U.S. market share; ~10% estimated 2019-30 annual U.S. market growth.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "324a2d9a-2982-4ccc-ad0a-32176001459f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.6,
        "w": 0.2,
        "x": 0.77,
        "y": 0.2
      },
      "kind": "paragraph",
      "text": "Expanding Into New Product Categories: XIPERE first therapy for suprachoroidal space; ~$433M forecasted 2022 uveitis market.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "528c3f39-20a4-400b-9f73-dad93d95ccd5",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.6,
        "w": 0.2,
        "x": 0.32,
        "y": 0.2
      },
      "kind": "paragraph",
      "text": "Continued Momentum in Key Portfolios: ~33% market share in U.S. consumer eye care; +13% Surgical organic revenue growth.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c4145252-01b8-44c4-b0ba-09fc5101d152",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.9,
        "x": 0.05,
        "y": 0.9
      },
      "kind": "source-note",
      "text": "1. This is a non-GAAP measure... 7. 2021 Clarivate",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "07d54f5d-4f45-4576-b5e6-2489478ac324",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.23,
        "x": 0.047,
        "y": 0.075
      },
      "kind": "title",
      "text": "1Q22 Highlights",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5672f5cd-a2db-48c5-b6a6-4f656476042c",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 7,
      "from": 5,
      "beatId": "161da3ed-91ef-48f6-aa16-b844b0a6ad76",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Problem",
      "beatSlug": "sequoia-pitch-problem",
      "evidence": "The deck introduces the company and its current situation",
      "position": 0,
      "confidence": 0.7,
      "parentBeatName": "Complication",
      "parentBeatSlug": "complication"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}